Orano Med
Amanda Reyes is a skilled professional with extensive experience in the life sciences and operations management. Currently serving as GMP Operations Manager at Orano Med since October 2015, Amanda has held several roles within the company, including Associate Scientist and various Lab Specialist positions. Prior to Orano Med, Amanda worked as a Laboratory Technician at Macrocyclics for a brief period in 2015 and gained early experience as a Sandwich Artist at Subway and a Sales Associate at TJ Maxx. Amanda's foundation in the field of zoology and animal biology was established with a Bachelor's Degree from Oklahoma State University, completed in 2015.
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.